Aripiprazol NOBEL 5 mg

Aripiprazol NOBEL 5 mg is a medicine authorised by Swissmedic under authorisation number 67607. The authorisation holder is NOBEL Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 31 October 2019 and the authorisation is valid without a time limit. ATC code N05AX12 places the medicine in the group Psycholeptics.

  • Dispensing category B
  • Authorisation number 67607
  • ATC N05AX12
  • Synthetic medicines
Authorisation data
Authorisation number67607
NameAripiprazol NOBEL 5 mg
Full nameAripiprazol NOBEL 5 mg, Tabletten
Authorisation holderNOBEL Pharma Schweiz AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN05AX12
First authorisation31 October 2019
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Aripiprazol NOBEL 5 mg, TablettenB31 October 2019
2Aripiprazol NOBEL 10 mg, TablettenB31 October 2019
3Aripiprazol NOBEL 15 mg, TablettenB31 October 2019
4Aripiprazol NOBEL 30 mg, TablettenB31 October 2019

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
128Tablette(n)N05AX1201.05.0.B
298Tablette(n)N05AX1201.05.0.B
328Tablette(n)N05AX1201.05.0.B
498Tablette(n)N05AX1201.05.0.B
528Tablette(n)N05AX1201.05.0.B
698Tablette(n)N05AX1201.05.0.B
728Tablette(n)N05AX1201.05.0.B
898Tablette(n)N05AX1201.05.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Aripiprazol NOBEL 5 mg authorised in Switzerland?

Yes. Aripiprazol NOBEL 5 mg is authorised by Swissmedic under authorisation number 67607, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Aripiprazol NOBEL 5 mg have?

Aripiprazol NOBEL 5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Aripiprazol NOBEL 5 mg?

The authorisation holder is NOBEL Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com